201 related articles for article (PubMed ID: 2368791)
1. Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease.
Groen H; Wichers G; ter Borg EJ; van der Mark TW; Wouda AA; Kallenberg CG
Am J Med; 1990 Jul; 89(1):34-41. PubMed ID: 2368791
[TBL] [Abstract][Full Text] [Related]
2. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
Kallenberg CG
Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases.
Ohtsuka T
Int J Dermatol; 1999 Oct; 38(10):757-64. PubMed ID: 10561047
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease.
Ohtsuka T; Tamura T; Yamakage A; Yamazaki S
Br J Dermatol; 1998 Oct; 139(4):622-9. PubMed ID: 9892906
[TBL] [Abstract][Full Text] [Related]
5. Serial nailfold capillary microscopy in primary Raynaud's phenomenon and scleroderma.
ter Borg EJ; Piersma-Wichers G; Smit AJ; Kallenberg CG; Wouda AA
Semin Arthritis Rheum; 1994 Aug; 24(1):40-7. PubMed ID: 7985036
[TBL] [Abstract][Full Text] [Related]
6. Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease?
Houtman PM; Kallenberg CG; Wouda AA; The TH
Ann Rheum Dis; 1985 Sep; 44(9):603-9. PubMed ID: 4037886
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns.
Groen H; ter Borg EJ; Postma DS; Wouda AA; van der Mark TW; Kallenberg CG
Am J Med; 1992 Dec; 93(6):619-27. PubMed ID: 1466357
[TBL] [Abstract][Full Text] [Related]
8. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
Schlager O; Kiener HP; Stein L; Hofkirchner J; Zehetmayer S; Ristl R; Perkmann T; Smolen JS; Koppensteiner R; Gschwandtner ME
Scand J Rheumatol; 2014; 43(3):226-33. PubMed ID: 24517537
[TBL] [Abstract][Full Text] [Related]
9. Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon.
Pavlov-Dolijanovic S; Damjanov NS; Stojanovic RM; Vujasinovic Stupar NZ; Stanisavljevic DM
Rheumatol Int; 2012 Oct; 32(10):3039-45. PubMed ID: 21901350
[TBL] [Abstract][Full Text] [Related]
10. The relation between nailfold bleeding and capillary microscopic abnormality in patients with connective tissue diseases.
Ohtsuka T
Int J Dermatol; 1998 Jan; 37(1):23-6. PubMed ID: 9522233
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
Houtman PM; Kallenberg CG; Fidler V; Wouda AA
J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
[TBL] [Abstract][Full Text] [Related]
12. Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud's disease.
Nagy Z; Czirják L
J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):62-8. PubMed ID: 14678534
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients.
Furtado RN; Pucinelli ML; Cristo VV; Andrade LE; Sato EI
Lupus; 2002; 11(1):35-41. PubMed ID: 11899953
[TBL] [Abstract][Full Text] [Related]
14. Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease.
Maricq HR; Harper FE; Khan MM; Tan EM; LeRoy EC
Clin Exp Rheumatol; 1983; 1(3):195-205. PubMed ID: 6335855
[TBL] [Abstract][Full Text] [Related]
15. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.
Lee P; Sarkozi J; Bookman AA; Keystone EC; Armstrong SK
J Rheumatol; 1986 Jun; 13(3):564-9. PubMed ID: 3735278
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of the evolution of Raynaud's phenomenon.
Fitzgerald O; Hess EV; O'Connor GT; Spencer-Green G
Am J Med; 1988 Apr; 84(4):718-26. PubMed ID: 3261127
[TBL] [Abstract][Full Text] [Related]
17. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
Navon P; Yarom A; Davis E
J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
[TBL] [Abstract][Full Text] [Related]
19. Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud's phenomenon.
Farenhorst CA; Roon AM; Gessel AI; Stel AJ; Bootsma H; Armbrust W; Mulder DJ
Pediatr Rheumatol Online J; 2022 Feb; 20(1):11. PubMed ID: 35135560
[TBL] [Abstract][Full Text] [Related]
20. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis.
Bukhari M; Herrick AL; Moore T; Manning J; Jayson MI
Br J Rheumatol; 1996 Nov; 35(11):1127-31. PubMed ID: 8948300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
